Coronary/Structural Heart Boston Scientific says Lotus out until Next Year Share by Ken Dropiewski on February 2, 2018 More in Coronary/Structural Heart: Vesalio Announces Late-Breaking Clinical Trial Presentation of the enVast NATURE Study at the ESC Congress 2026 July 21, 2026 FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol July 17, 2026 A breakthrough in coronary bypass surgery: AMT Medical’s SAFE-CAB results published in The Journal of Thoracic and Cardiovascular Surgery July 16, 2026 Share this story Facebook Twitter LinkedIn Lotus Valve to Stay Off the Shelves Through 2018 Patrice Wendling – February 01, 2018, Medscape MARLBOROUGH, MA — The beleaguered Lotus heart valve system is not expected to launch in the US market until 2019, according to Boston Scientific officials. All Lotus valves were voluntarily recalled worldwide in February 2017 because of reports of early release of a pin connecting the transcatheter valve to the delivery system…. Read Full Article at Medscape here